2015
DOI: 10.5999/aps.2015.42.1.4
|View full text |Cite
|
Sign up to set email alerts
|

The Clinical Implications of Poly Implant Prothèse Breast Implants: An Overview

Abstract: Mammary implants marketed by Poly Implant Prothèse (PIP) were found to contain industrial grade silicone and this caused heightened anxiety and extensive publicity regarding their safety in humans. These implants were used in a large number of patients worldwide for augmentation or breast reconstruction. We reviewed articles identified by searches of Medline, PubMed, Embase, and Google Scholar databases up to May 2014 using the terms: "PIP", "Poly Implant Prothèse", "breast implants" and "augmentation mammopla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0
9

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 29 publications
(46 reference statements)
0
6
0
9
Order By: Relevance
“…11 However, there is no evidence that chronic human exposure to siloxanes with levels found in the rupture condition of PIP implants is carcinogenic. 12 …”
Section: Discussionmentioning
confidence: 99%
“…11 However, there is no evidence that chronic human exposure to siloxanes with levels found in the rupture condition of PIP implants is carcinogenic. 12 …”
Section: Discussionmentioning
confidence: 99%
“…Guidelines for the optimal use of ADM are still evolving and are the focus of intense research and training [ 16 ]. Advancements in liposuction techniques that yield a high success rate after autologous fat transplant have led to the development of lipo-modelling techniques as an adjunct in restoring cosmetic defects after breast-conserving surgery and enhancing the cosmetic appearance of a reconstructed breast [ 17 18 19 ].…”
mentioning
confidence: 99%
“…5,6 The U.S had not been involved in the PIP crisis, 7 but the European countries and Australia have reacted in different ways to this issue [7][8][9][10] which clinical implications have been reviewed recently. 11 In March 2010, the French national regulation agency (AFFSAPS) requested that doctors' call back all women who had undergone breast reconstruction/augmentation based on PIP implants. The PIP recall was because the implants were produced with a non-homologated silicone gel.…”
mentioning
confidence: 99%